Neurogene (NGNE) Total Liabilities (2013 - 2026)

Neurogene's Total Liabilities history runs 14 years deep, the most recent figure standing at $25.4 million for Q1 2026.

• Quarterly Total Liabilities rose 7.88% year-over-year to $25.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.4 million (up 7.88% YoY) and the FY2025 annual result came in at $23.7 million, down 6.46% from the prior year.
• Total Liabilities was $25.4 million for Q1 2026 at Neurogene, up from $23.7 million in the prior quarter.
• Across five years, Total Liabilities topped out at $36.5 million in Q4 2023 and bottomed at $10.6 million in Q4 2022.
• A 5-year average of $22.0 million and a median of $23.5 million in 2025 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities plunged 47.85% — and 2023, when it surged 243.57%.
• Neurogene's Total Liabilities stood at $10.6 million in 2022, then jumped by 243.57% to $36.5 million in 2023, then sank by 30.63% to $25.4 million in 2024, then slipped by 6.46% to $23.7 million in 2025, then advanced by 6.92% to $25.4 million in 2026.
• Business Quant data shows NGNE's Total Liabilities at $25.4 million in Q1 2026, $23.7 million in Q4 2025, and $22.3 million in Q3 2025.